Parasitic diseases have seriously threatened livestock, aquaculture, crops, forestry, and humans due to their widespread prevalence and infectivity, causing huge economic losses. Parasitological research has lagged relatively behind the development of bacteriology and virology in many aspects. In recent years, with the international community's changing awareness of the dangers of parasitic diseases, investment in basic parasitological research has gradually increased. The rapid development of parasitology, especially molecular parasitology, has to some extent also contributed to the overall pace of life science research. As more and more parasite genome sequences are resolved, it provides unprecedented opportunities for the identification of parasite species, genetic diagnosis of diseases, important pathogenic mechanisms, the discovery of new antigenic molecules and metabolic pathways, and screening of new antiparasitic drugs. Vaccine immunization remains an important means of preventing parasitic diseases. With the continuous research on parasite-related genes and antigenic structures in recent years, significant progress has been made in the development of genetically engineered vaccines.
As one of the advanced experimental tools in modern molecular biology research, our genetic engineering services for parasitic organisms for global clients have widely penetrated into various research directions of parasitology and played a very important role in basic research, vaccine preparation, and other fields. With the advantage of professional technology, Ace Therapeutics' comprehensive technology platform for parasitic organisms is equipped with efficient instruments and a professional team to provide you with gene editing, and gene transfection services for Toxoplasma gondii, Schistosoma mansoni, Trypanosoma, Babesia, Leishmania, Phages and so on. Including but not limited to the following:
CRISPR/Cas9 Genome Editing Service of Toxoplasma gondii
CRISPR/Cas9 Genome Editing Service of Plasmodium
CRISPR/Cas9 Genome Editing Service of Trypanosoma
CRISPR/Cas9 Genome Editing Service of Schistosoma mansoni
CRISPR/Cas9 Genome Editing Service of Babesia
Note: In addition to these types of genetic engineering services for parasitic organisms, we can also provide genetic engineering services for other types of parasitic organisms and personalized services. Please contact us for details.
You can fill in your project description, the services/products you are interested in, and your contact information through online inquiry, and we will contact you as soon as possible!
As a leading global parasitology research service provider, Ace Therapeutics has established a first-class comprehensive service platform for parasitic biotechnology, with business covering basic research services in parasitic biology and non-clinical medical research technology services, effectively supporting the research needs in the field of parasitic biology. We can provide global customers with genetic engineering services for parasitic organisms, including but not limited to gene transfection and gene editing services for various types of parasitic organisms.
Ace Therapeutics is a contract service provider focused on parasitology research, providing innovative solutions and technologies for parasite detection, genetic engineering, and drug development. We support global research institutes, universities, and pharmaceutical companies in advancing their research goals.